CREM and esophageal squamous cell carcinoma: Lower CREM expression was associated with a higher risk of metastasis as well as a poorer response to cisplatin, a treatment used in ESCC among many other cancers.8 Further studies are warranted to demonstrate the mechanisms behind altered CREM expression, and the consequences thereof, in other forms of cancer.